no code implementations • 28 Mar 2025 • Bowen Gao, Yanwen Huang, Yiqiao Liu, Wenxuan Xie, Wei-Ying Ma, Ya-Qin Zhang, Yanyan Lan
The discovery of novel small molecule drugs remains a critical scientific challenge with far-reaching implications for treating diseases and advancing human health.
no code implementations • 3 Mar 2025 • Bowen Gao, Yanwen Huang, Yiqiao Liu, Wenxuan Xie, Wei-Ying Ma, Ya-Qin Zhang, Yanyan Lan
Structure-Based Drug Design (SBDD) has revolutionized drug discovery by enabling the rational design of molecules for specific protein targets.
no code implementations • 5 Feb 2025 • Junguang Jiang, Yanwen Huang, Bin Liu, Xiaoyu Kong, Xinhang Li, Ziru Xu, Han Zhu, Jian Xu, Bo Zheng
In real-world recommender systems, different retrieval objectives are typically addressed using task-specific datasets with carefully designed model architectures.
no code implementations • 2 Jan 2025 • Yanwen Huang, Yong Zhang, Ning Cheng, Zhitao Li, Shaojun Wang, Jing Xiao
Large language models (LLMs) often suffer from context faithfulness hallucinations, where outputs deviate from retrieved information due to insufficient context utilization and high output uncertainty.
1 code implementation • 13 Jun 2024 • Shikun Feng, Jiaxin Zheng, Yinjun Jia, Yanwen Huang, Fengfeng Zhou, Wei-Ying Ma, Yanyan Lan
We believe this dataset will serve as a more accurate and reliable benchmark for molecular representation learning, thereby expediting progress in the field of artificial intelligence-driven drug discovery.
1 code implementation • 13 Jun 2024 • Bowen Gao, Haichuan Tan, Yanwen Huang, Minsi Ren, Xiao Huang, Wei-Ying Ma, Ya-Qin Zhang, Yanyan Lan
Recent advancements in structure-based drug design (SBDD) have significantly enhanced the efficiency and precision of drug discovery by generating molecules tailored to bind specific protein pockets.
1 code implementation • 13 Jun 2024 • Yanwen Huang, Bowen Gao, Yinjun Jia, Hongbo Ma, Wei-Ying Ma, Ya-Qin Zhang, Yanyan Lan
Small molecules play a pivotal role in modern medicine, and scrutinizing their interactions with protein targets is essential for the discovery and development of novel, life-saving therapeutics.
no code implementations • 15 May 2024 • Shikun Feng, Yuyan Ni, Minghao Li, Yanwen Huang, Zhi-Ming Ma, Wei-Ying Ma, Yanyan Lan
Recently, a noticeable trend has emerged in developing pre-trained foundation models in the domains of CV and NLP.
no code implementations • 4 Mar 2024 • Bowen Gao, Minsi Ren, Yuyan Ni, Yanwen Huang, Bo Qiang, Zhi-Ming Ma, Wei-Ying Ma, Yanyan Lan
In the field of Structure-based Drug Design (SBDD), deep learning-based generative models have achieved outstanding performance in terms of docking score.
1 code implementation • 22 Oct 2023 • Shikun Feng, Lixin Yang, Yanwen Huang, Yuyan Ni, WeiYing Ma, Yanyan Lan
Molecular representation learning is fundamental for many drug related applications.